Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-16

Clinical Trial Update: The Drug-drug Interaction of SHR3824 and Metformin [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the drug-drug interaction between SHR3824 and metformin in type 2 diabetes mellitus has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SHR3824
  • metformin (metformin)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED